Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells

Immunology

Volumn 89, Issue 1, 1996, Pages 59-67

  Ulmer, J B ^a   Deck, R R ^a   Dewitt, C M ^a   Donnelly, J J ^a   Liu, M A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL;

EID: 0029789751     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-718.x     Document Type: Article

References (32)

1. WOLFF J.A., MALONE R.W., WILLIAMS P. et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465.
2. DONNELLY J.J., ULMER J.B. & LIU M.A. (1994) Immunization with DNA. J Immunol Methods 176, 145.
3. ULMER J.B., DONNELLY J.J., PARKER S.E. et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745.
4. TANG, D.-C., DEVH M. & JOHNSTON S.A. (1992) Genetic immunisation is a simple method for eliciting an immune response. Nature 356, 152.
5. DAVIS H.L., WILNIEN R.G. & DEMENEIN B.A. (1993) Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 4, 151.
6. MANIHORPI M., CORNELIRI-JENSEN F., HARUKKA J. et al. (1993) Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum Gene Ther 4, 419.
7. WOLFF J.A., DOWTY M.E., JIAO S. et al. (1992) Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J Cell Sci 103, 1249.
8. NICHOLS W.W., LEDWITH B.J., MANAM S.V. & TROILO P.J. (1995) Potential DNA vaccine integration into host cell genome. Ann NY Acad Sci 772, 30.
9. LEW D., PARKER S.E., LAHMER T. et al. (1995) Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum Gene Ther 6, 553.
10. TAUIU C., JASMIN C. & SOLYMOSS, B. (1981) Growth of neonatal hamster skeletal muscle in culture. Muscle Nerve 4, 149.
11. MONTGOMERY D.L., SHIVER J.M., LEANDER K.R et al. (1993) Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of vectors. DNA Cell Biol 12, 777.
12. BAO S., KING, N.J.C. & DOS REMEDIOS C.G. (1990) Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with γ-interferon. Immunol Cell Biol 68, 235.
13. ULMER J.B., DICK R.R., DEWITT C.M., FRIEDMAN A., DONNELLY J.J. & LIU M.A. (1994) Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12, 1541.
14. BARR E. & LEIDEN J.M. (1991) Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507.
15. WRAHH D.C., VISSEY A.E. & ASKONIS B.A. (1987) Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol 68, 433.
16. DONNELLY J.J., ULMER J.B. & LIU M.A. (1995) Protective efficacy of intramuscular immunization with naked DNA. Ann NY Acad Sci 772, 40.
17. KRIEG A.M., YI A.-K., MAISON S. et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546.
18. STILZ L., SCHMITZ C., BINDER D., ZINKERNAGEL R., PAOLETTI E. & BECHT H. (1990) Characterization and immunological properties of influenza A virus nucleoprotein (NP): Cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. J Gen Virol 71, 1169.
19. WARRENS A.N., ZHANG J.Y., SIDHU S. et al. (1994) Myoblasts fail to stimulate T cells but induce tolerance. Int Immunol 6, 847.
20. KNECHTLE S.J., WANG J., JIAO S., GEISSLER E.K., SUMIMOTO R. & WOLFF J. (1994) Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplant 57, 990.
21. GOEBELS N., MICHAELIS D., WEKERLE H. & HOHLFIELD R. (1992) Human myoblasts as antigen presenting cells. J Immunol 149, 661.
22. GRABSTEIN K.H., EISENMAN J., SHANEBECK K. et al. (1994) Cloning of a T cell growth factor that interacts with β chain of the interleukin-2 receptor. Science 264, 965.
23. c chain of the IL-2 receptor. Science 266, 1039.
24. KÜNDIG, T.M., BACHMANS M.F., DIPAOLO C. et al. (1995) Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268, 1343.
25. KARPATI G., POULIOT Y. & CARPENTER S. (1988) Expression of immunoreactive major histocompatibility complex proteins in human skeletal muscles. Ann Neurol 23, 64.
26. SAJJADI N., KAMANTIQUE E., EDWARDS W. et al. (1994) Recombinant retroviral vector delivered intramuscularly localizes to the site of injection in mice. Hum Gene Ther 5, 693.
27. HUANG A.Y.C., GOLUMBER P., AHMADZADEH M., JAFFEE E., PARDOLL D.M. & LEVISTSKY H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961.
28. XIANG, Z.Q. & ERTL H.C.J. (1995) Manipulation of the immune response to a plasmid-endcoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129.
29. ROCK K.L., ROTHSTEIN L., GAMBLE S. & FLEISCHACKER C. (1993) Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150, 438.
30. MILLER D.G., ADAM M.A. & MILLER A.D. (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10, 4239.
31. WOLFF J.A., LUDTKE J.J., ACSADI G., WILLIAMS P. & JANI A. (1992) Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1, 363.
32. GRAY D. & MATZINGER P. (1991) T cell memory is short-lived in the absence of antigen. J Exp Med 174, 969.